You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

HYDERGINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Hydergine patents expire, and what generic alternatives are available?

Hydergine is a drug marketed by Novartis and is included in four NDAs.

The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDERGINE?
  • What are the global sales for HYDERGINE?
  • What is Average Wholesale Price for HYDERGINE?
Summary for HYDERGINE
US Patents:0
Applicants:1
NDAs:4
Raw Ingredient (Bulk) Api Vendors: 15
Patent Applications: 105
DailyMed Link:HYDERGINE at DailyMed
Drug patent expirations by year for HYDERGINE

US Patents and Regulatory Information for HYDERGINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis HYDERGINE ergoloid mesylates SOLUTION;ORAL 018418-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis HYDERGINE ergoloid mesylates TABLET;SUBLINGUAL 009087-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis HYDERGINE ergoloid mesylates TABLET;ORAL 017993-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for HYDERGINE

See the table below for patents covering HYDERGINE around the world.

Country Patent Number Title Estimated Expiration
Ireland 47791 STABLE SOLUTIONS OF HYDROGENATED ERGOPEPTIDE ALKALOIDS ⤷  Sign Up
U.S.S.R. 952106 PROCESS FOR PRODUCING STABLE SOLUTIONS OF DERIVATIVES OF ERGOT ALKALOIDS OR THEIR SALTS ⤷  Sign Up
Norway 782605 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.